HomeTOP STORIESNektar therapeutics outlines REZOLVE-AD phase 2b data and financial position for Q2... Nektar therapeutics outlines REZOLVE-AD phase 2b data and financial position for Q2 2025 By rogerjudd May 9, 2025 FacebookTwitterPinterestWhatsApp Post Content Previous articleOwlet raises 2025 revenue guidance to $91M-$95M amid strong Q1 growthNext articleZymeworks outlines robust pipeline advancements and financial resilience through 2027 latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds
